Another study found that the protein level of TLR6, but not TLR2, was gradually increased in the hepatocytes from the cohorts of NAFLD and NASH patients compared to those from normal liver biopsy, indicating that TLR6 contributed to inflammatory responses in the development of NASH (46). Here, TLR2 is linked to metabolic dysfunction-associated steatotic liver disease.